Abstract
BACKGROUND: Advances in medical care have led to improved survival rates of extremely premature infants but the incidence of bronchopulmonary dysplasia (BPD) has not changed in the last two decades. Animal data suggests that erythropoietin treatment could ameliorate pulmonary vascular and alveolar development in neonatal models of BPD OBJECTIVE: To determine whether premature infants treated with erythropoietin (EPO) in …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have